Multiple Sclerosis

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Riordan, J I
Right arrow Articles by Miller, D H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Riordan, J I
Right arrow Articles by Miller, D H
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Multiple Sclerosis, Vol. 4, No. 5, 408-412 (1998)
DOI: 10.1177/135245859800400502

T1 hypointense lesion load in secondary progressive multiple sclerosis: a comparison of pre versus post contrast loads and of manual versus semi automated threshold techniques for lesion segmentation

J I O'Riordan

NMR Research Group, The Institute of Neurology, Queen Square, London WC1N 3BG

M Gawne Cain

NMR Research Group, The Institute of Neurology, Queen Square, London WC1N 3BG

A Coles

Department of Neurology, Addenbrookes Hospital, Hills Road, Cambridge CB2 2QQ, UK

L Wang

NMR Research Group, The Institute of Neurology, Queen Square, London WC1N 3BG

D AS Compston

Department of Neurology, Addenbrookes Hospital, Hills Road, Cambridge CB2 2QQ, UK

P Tofts

NMR Research Group, The Institute of Neurology, Queen Square, London WC1N 3BG

D H Miller

NMR Research Group, The Institute of Neurology, Queen Square, London WC1N 3BG

Magnetic resonance imaging (MRI) is increasingly being used as a monitoring tool for disease activity in therapeutic trials in multiple sclerosis. There is, however, only a limited relationship between MRI findings and clinical outcome measurements. It has been suggested that hypointense lesion load on T1 weighted imaging has a better correlation with disability than the more conventional T2 hyper intense lesion load. This study was undertaken to (i) evaluate different measurement techniques used to quantify T1 hypointense lesion load, and (ii) to compare lesion load as measured using different parameters and disability. Twenty-five patients with secondary progressive multiple sclerosis, mean age of 40 years (23-57), mean EDSS 5.7 (4-7) were analysed. T2 lesion load on FSE correlated well with both the hypointense lesion load on T1 pre-gadolinium (r=0.8, P50.0001) and T1 post-gadolinium (r=0.8, P50.0001) but less so with the enhancing lesion load (r=0.4, P50.05). There was a very strong correlation with T1 hypo-intense lesion volume pre and post gadolinium (r=0.96, P50.001). However, the EDSS was not correlated with the T2 lesion load (r=70.27, P=0.2), T1 pre-gadolinium load (r=70.3, P=0.1), T1 post gadolinium load (r=70.4, P=0.7) and enhancing lesion load (r=70.28, P=0.2), or with the degree of hypointensity of T1 weighted images determined using the threshold technique. There is a strong correlation between T1 hypointense lesion volume both pre and post gadolinium and also between T1 and T2 lesion volumes.

Key Words: multiple sclerosis • T1 hypointense lesion load


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arch NeurolHome page
R. T. Naismith and A. H. Cross
Multiple Sclerosis and Black Holes: Connecting the Pixels
Arch Neurol, November 1, 2005; 62(11): 1666 - 1668.
[Full Text] [PDF]


Home page
Mult SclerHome page
S J Hickman, G J Barker, P D Molyneux, and D H Miller
Technical note: the comparison of hypointense lesions from 'pseudo-T1' and T1-weighted images in secondary progressive multiple sclerosis
Multiple Sclerosis, October 1, 2002; 8(5): 433 - 435.
[Abstract] [PDF]


Home page
NeurologyHome page
P. A. Brex, P. D. Molyneux, P. Smiddy, F. Barkhof, M. Filippi, T. A. Yousry, D. Hahn, Y. Rolland, O. Salonen, C. Pozzilli, et al.
The effect of IFN{beta}-1b on the evolution of enhancing lesions in secondary progressive MS
Neurology, December 26, 2001; 57(12): 2185 - 2190.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
F. Barkhof, J.-H. T. M. van Waesberghe, M. Filippi, T. Yousry, D. H. Miller, D. Hahn, A. J. Thompson, L. Kappos, P. Brex, C. Pozzilli, et al.
T1 hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment
Brain, July 1, 2001; 124(7): 1396 - 1402.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
J. A. Koziol, S. Wagner, D. F. Sobel, L. S. Slivka, J. S. Romine, J. C. Sipe, and H.-P. Adams
Predictive Value of Lesions for Relapses in Relapsing-remitting Multiple Sclerosis
AJNR Am. J. Neuroradiol., February 1, 2001; 22(2): 284 - 291.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. A. A. van Walderveen, G. J. Lycklama a Nijeholt, H. J. Ader, P. J. H. Jongen, C. H. Polman, J. A. Castelijns, and F. Barkhof
Hypointense Lesions on T1-Weighted Spin-Echo Magnetic Resonance Imaging: Relation to Clinical Characteristics in Subgroups of Patients With Multiple Sclerosis
Arch Neurol, January 1, 2001; 58(1): 76 - 81.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
P. D Molyneux, P. A Brex, C. Fogg, S. Lewis, C. Middleditch, F. Barkhof, M. P Sormani, M. Filippi, and D. H Miller
The precision of T1 hypointense lesion volume quantification in multiple sclerosis treatment trials: a multicenter study
Multiple Sclerosis, August 1, 2000; 6(4): 237 - 240.
[Abstract] [PDF]


Home page
NeurologyHome page
J. H. Simon, J. Lull, L. D. Jacobs, R. A. Rudick, D. L. Cookfair, R. M. Herndon, J. R. Richert, A. M. Salazar, J. Sheeder, D. Miller, et al.
A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon {beta}-1a
Neurology, July 25, 2000; 55(2): 185 - 192.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. S. Wolinsky, P. A. Narayana, J. H. Noseworthy, F. D. Lublin, J. N. Whitaker, A. Linde, P. Gjorstrup, and H. C. Sullivan
Linomide in relapsing and secondary progressive MS: Part II: MRI results
Neurology, May 9, 2000; 54(9): 1734 - 1741.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P A Brex, G J M Parker, S M Leary, P D Molyneux, G J Barker, C A Davie, A J Thompson, and D H Miller
Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations
J. Neurol. Neurosurg. Psychiatry, May 1, 2000; 68(5): 627 - 632.
[Abstract] [Full Text]